Bio

Robert Darwin has a broad international practice focused on private equity, M&A, and complex licensing and collaborations. Robert advises clients across a wide range of industries including industrials, consumer goods, and leisure, and is particularly known for his work with global life sciences, healthcare and technology corporations, and investors. Robert has been recommended and recognized for his work for a number of years in The Legal 500 UK (M&A: Upper Mid-Market and Premium deals, and also Life Sciences and Healthcare) and Chambers UK (Life Sciences Transactional).